Edition:
United States

Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

46.62USD
9 Dec 2016
Change (% chg)

$-0.64 (-1.35%)
Prev Close
$47.26
Open
$46.74
Day's High
$47.42
Day's Low
$46.52
Volume
35,485
Avg. Vol
56,216
52-wk High
$54.70
52-wk Low
$40.74

Select another date:

Fri, Nov 11 2016

BRIEF-Dr.Reddy's Laboratories announces launch of Raloxifene HCI tablets in the U.S.

* Announces the launch of Raloxifene HCI tablets, USP in the U.S. Market Source text: http://bit.ly/2fHr5V4 Further company coverage:

BRIEF-Sucampo Q3 adjusted EPS $0.28

* Sucampo pharmaceuticals inc - company raises 2016 guidance and provides preliminary 2017 guidance

BRIEF-Dr.Reddy's Labs exec says co has addressed all FDA requirements on warning letters

* Exec says have addressed all FDA requirements on warning letters

BRIEF-Dr.Reddy's Laboratories Sept-qtr consol profit falls 60 pct

* Co to continue to focus on launching new products in generic business

BRIEF-Dr. Reddy's Labs launches Aripiprazole tablets, USP tablets in U.S. market

* Dr. Reddy's Laboratories announces the launch of Aripiprazole tablets, USP tablets in the U.S. market Source text for Eikon: Further company coverage: (Bengaluru newsroom)

BRIEF-Dr.Reddy's launches Lamotrigine Orally Disintegrating tablets in U.S

* Announces the launch of Lamotrigine Orally Disintegrating tablets in the U.S. market Source text: http://bit.ly/2dFkVt2 Further company coverage:

BRIEF-Dr.Reddy's Labs announces entry into Columbia

* Announces entry into Columbia Source text: http://bit.ly/2dzOUiD Further company coverage: (Bengaluru newsroom)

BRIEF-DR. Reddy's laboratories says launch of Bupropion HCL extended-release tablets, USP (sr) in U.S. market

* Launch of bupropion hcl extended-release tablets, usp (sr) in u.s. Market Source text for Eikon: Further company coverage:

Select another date: